Elevated serum growth hormone in a patient with Type 1 diabetes: a diagnostic dilemma
β Scribed by O. M. Herlihy; P. Perros
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 179 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1520-7552
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hypoglycaemic episodes and low insulin requirements are frequently seen in the early phase of treatment of Type 1 diabetes mellitus but the mechanism is not clear. We present a diabetic patient with recurrent hypoglycaemia in the early phase of insulin treatment. A very high glucose transport in adi
## The incidence of nephropathy in Type 1 diabetes mellitus has declined during the past decade, probably as a result of improved glycaemic control. We wanted to investigate whether the incidence of severe retinopathy has changed during the same time period and to evaluate the importance of glycae
## Abstract ## BACKGROUND The authors measured circulating vascular endothelial growth factorβC (VEGFβC) and vascular endothelial growth factor (VEGF) levels in patients with primary nonsmall cell lung carcinoma and assessed its usefulness as a diagnostic tool for determining lymph node metastasis
The effect of the apolipoprotein (apo) E genotype on the lipoprotein response to a 1 year low cholesterol diet (200 mg cholesterol per day) was evaluated in 36 patients with Type 1 diabetes mellitus with albuminuria between 10 and 200 g min Ψ1 . Apo E genotype was characterized by polymerase chain r